European Journal of Clinical Pharmacology

, Volume 23, Issue 4, pp 365–367 | Cite as

Lack of effect of cimetidine on action of phenprocoumon

  • J. Harenberg
  • R. Zimmermann
  • Ch. Staiger
  • J. X. de Vries
  • E. Walter
  • E. Weber
Originals

Summary

In patients on oral warfarin, nicoumalone and phenindione an increase in the anticoagulant effect has been described during concomitant treatment with cimetidine. Therefore the effect of cimetidine on the steady state dynamics of phenprocoumon has been investigated in ten outpatients. No change in the anticoagulant effect of phenprocoumon was observed during or after two weeks on cimetidine, as measured by the thrombotest coagulation method, prothrombin time, fibrinopeptide A concentration and plasma phenprocoumon level. The data show that cimetidine does not interact with the metabolism of phenprocoumon in contrast to warfarin. Thus, phenprocoumon maintenance therapy when combined with concomitant cimetidine treatment can be considered not to carry an increased risk of haemorrhagic complications.

Key words

cimetidine phenprocoumon warfarine drug metabolism interaction histamine receptor antagonist anticoagulation bleeding complication 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Flind CA (1978) Cimetidine and oral anticoagulants. Br Med J 2: 1367Google Scholar
  2. 2.
    Serlin MJ, Sibeon RG, Mossman S, Breckenridge AM, Williams JRB, Atwood JL, Willoughby JMT (1979) Cimetidine: Interaction with oral anticoagulants in man. Lancet 2: 317–319Google Scholar
  3. 3.
    Quick AJ (1935) The prothrombin in hemophilia and in obstructive jaundice. J Biol Chem 109: 72–79Google Scholar
  4. 4.
    Owren PA (1959) Thrombotest — a new method for controlling anticoagulant therapy. Lancet 2: 754–758Google Scholar
  5. 5.
    Zimmermann R, Hofrichter A, Walter E, Ehlers W, Andrassy K, Lang PD, Schlierf G, Weber E, Barth P (1977) Orale Antikoagulation und Thrombocytenfunktion bei hyperlipämischer Behandlung mit einem neuen Clofibrat-Analog (BM 15 075). Dtsch Med Wochenschr 102: 509–513Google Scholar
  6. 6.
    Clauss A (1957) Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 17: 237–241Google Scholar
  7. 7.
    Harenberg J, Hepp G, Schmidt-Gayk H (1979) Fibrinopeptide A in human plasma-evaluation of a new radio immunoassay technique on microtiter plates. Thromb Res 15: 513–522Google Scholar
  8. 8.
    de Vries JX, Harenberg J, Walter E, Weber E, Zimmermann R (1982) Determination of Phenprocoumon in human plasma and urine by high performance liquid chromatography. Chromatogr 231: 83–92Google Scholar
  9. 9.
    Nossel HL, Ti M, Kaplan KL, Spanondis K, Soland T, Butler VP (1976) The generation of fibrinopeptide A in clinical blood samples. Evidence for thrombin activity. J Clin Invest 58: 1136–1144Google Scholar
  10. 10.
    Harenberg J, Haas R, Zimmermann R (1981) Measurement of fibrinopeptide A in patients treated with phenprocoumon. Thromb Haemostas 45: 282–284Google Scholar
  11. 11.
    Heni N, Glogner P (1976) Pharmacokinetics of phenprocoumon in man investigated using a gas chromatographic method of drug analysis. Naunyn-Schmiedeberg's Arch Pharmacol 293: 183–186Google Scholar
  12. 12.
    Haddock RE, Trager WF (1975) Biotransformation of Phenprocoum in the rat. J Med Chem 18: 519–523Google Scholar
  13. 13.
    Wheeler C, Trager WF, Porter WR (1981) Stereochemical aspects of the metabolism of phenprocoumon in rat liver microsomes. Biochem Pharmacol 30: 1785–1790Google Scholar
  14. 14.
    Desmond PV, Patwardhan R, Parker R, Schenker S, Speeg KV (1980) Effect of cimetidine and other antihistaminics on the elimination of aminopyrine, phenacetin and caffeine. Life Sci 26: 1261–1268Google Scholar
  15. 15.
    Campbell MA, Plachetka JR, Jackson JE, Moon JF, Finley PR (1981) Cimetidine decreases theophylline clearance. Ann Int Med 95: 68–69Google Scholar
  16. 16.
    Daneshmend TK, Roberts CJC (1981) Cimetidine and bioavailability of labetalol. Lancet 1: 565Google Scholar
  17. 17.
    Hetzel DJ, Bochner F, Hallpike JF, Shearman DJC, Hann CS (1981) Cimetidine interaction with phenytoin. Br Med J 282: 1512Google Scholar
  18. 18.
    Klotz U, Reimann I (1980) Delayed clearance of diazepam due to cimetidine. N Engl J Med 302: 1012–1014Google Scholar
  19. 19.
    Klotz U, Reimann I (1980) Influence of cimetidine on the pharmacokinetics of desmethyldiazepam and oxazepam. Eur J Clin Pharmacol 18: 517–520Google Scholar
  20. 20.
    Desmond PV, Patwardhan RV, Schenker S, Speeg KV (1980) Cimetidine impairs elimination of chlordiazepoxide (Librium) in man. Ann Int Med 93: 266–268Google Scholar
  21. 21.
    Patwardhan RV, Yarborough GW, Desmond PV, Johnson RF, Schenker S, Speeg KV (1980) Cimetidine spares the glucuronidation of lorazepam and oxazepam. Gastroenterology 79: 912–916Google Scholar

Copyright information

© Springer-Verlag 1982

Authors and Affiliations

  • J. Harenberg
    • 1
  • R. Zimmermann
    • 1
  • Ch. Staiger
    • 1
  • J. X. de Vries
    • 1
  • E. Walter
    • 1
  • E. Weber
    • 1
  1. 1.Departments of Clinical Pharmacology and Internal Medicine IMedical Clinic (Ludolf Krehl Klinik) University of HeidelbergHeidelbergGermany

Personalised recommendations